HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Nanotech Guidance Takes Small Step Forward

This article was originally published in The Tan Sheet

Executive Summary

FDA initiates a dialogue with industry on nanotechnology in regulated products via a broad draft guidance document.

You may also be interested in...

FDA Draft Guidance Stretches Nanotech “Perhaps Massively” – Trade Group

FDA's draft guidance suggesting ingredients up to 1 micrometer in size that exhibit “altered properties” still qualify as nanomaterials should be revised to avoid confusion in the marketplace and promote international harmonization, according to the Personal Care Products Council.

CHPA Urges Nuanced, Risk-Based Approach To Nanotechnology

FDA should not use size alone to regulate nanotechnology, the Consumer Healthcare Products Association says.

Proposed Spray Sunscreen Warnings A Gateway For Nano Tort Litigation?

FDA’s proposed warnings on spray sunscreen product labeling could open the door to tort litigation, according to Jennifer Quinn-Barabanov, an attorney specializing in product liability.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts